27-29 June, 2016
The Marker San Francisco, San Francisco, CA
Senior Director, Product Development And Manufacturing Relypsa Inc
Dr. Hayat is Senior Director, Product Development, Manufacturing and Supply Chain at Relypsa, polymer based drug discovery company who launched Veltassa, treatment for hyperkalemia, in the US in December 2015. Dr. Hayat worked for three start-ups - Transcept (2005-08), Anacor (2008-11) and Relypsa (2011-16) where he played a key role development and approval of IntermezzoTM- treatment for middle of the night insomnia, Kerydin® - treatment for oncomycosis, and Veltassa® – treatment for hyperkalemia.
Dr. Hayat received his Ph.D. in chemical engineering from ENSIGC-INP de Toulouse, France. He was postdoctoral fellow at Ecole Polytechnique de Montreal, Canada.